Device Trial Radar · NCT04782297
Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)
Last checked: Nov 20, 2026Latest source record: Jan 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Mar 30, 2022
Primary completion
Mar 17, 2023
Study completion Mar 17, 2023
Sponsor
- Lead sponsor
- Medical Components, Inc dba MedCompNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Syneos Health; Veeva Systems
- First posted
- Mar 4, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this observational PMCF study is to collect clinical data on the safety and efficacy of Medcomp Long Term Hemodialysis (LTHD) Catheter Kits in compliance with MDR 2017/745.
Conditions
- CKD
- ESRD
Interventions
Long term hemodialysis catheterDevice
There will be no interventions in this study. Strictly observational.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Insertion SuccessTime frame: Percentage at Insertion
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
University of Maryland School of Medicine Vascular & Interventional Radiology Department
Baltimore, Maryland
Hospital Universitari Arnau de Vilanova
Lleida, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.